Vis enkel innførsel

dc.contributor.authorOlsman, Marieke
dc.contributor.authorSereti, Viktoria
dc.contributor.authorAndreassen, Kristine
dc.contributor.authorSnipstad, Linn Sofie
dc.contributor.authorvan Wamel, Johanna Elisabeth Theodora
dc.contributor.authorEliasen, Rasmus
dc.contributor.authorBerg, Sigrid
dc.contributor.authorUrquhart, Andrew J.
dc.contributor.authorAndresen, Thomas L.
dc.contributor.authorDavies, Ruth Catharina de Lange
dc.date.accessioned2020-08-25T07:04:32Z
dc.date.available2020-08-25T07:04:32Z
dc.date.created2020-07-22T11:06:12Z
dc.date.issued2020
dc.identifier.citationJournal of Controlled Release. 2020, 325 121-134.en_US
dc.identifier.issn0168-3659
dc.identifier.urihttps://hdl.handle.net/11250/2673754
dc.description.abstractTo improve therapeutic efficacy of nanocarrier drug delivery systems, it is essential to improve their uptake and penetration in tumour tissue, enhance cellular uptake and ensure efficient drug release at the tumour site. Here we introduce a tumour targeting drug delivery system based on the ultrasound-mediated delivery of enzyme sensitive liposomes. These enzyme sensitive liposomes are coated with cleavable poly(ethylene glycol) (PEG) which will be cleaved by two members of the enzyme matrix metalloproteinase family (MMP-2 and MMP-9). Cleavage of the PEG coat can increase cellular uptake and will destabilize the liposomal membrane which can result in accelerated drug release. The main aim of the work was to study the effect of focused ultrasound and microbubbles on the delivery and therapeutic efficacy of the MMP sensitive liposome. The performance of the MMP sensitive liposome was compared to a non-MMP sensitive version and Doxil-like liposomes. In vitro, the cellular uptake and cytotoxicity of the liposomes were studied, while in vivo the effect of ultrasound and microbubbles on the tumour accumulation, biodistribution, microdistribution, and therapeutic efficacy were investigated. For all tested liposomes, ultrasound and microbubble treatment resulted in an improved tumour accumulation, increased extravasation, and increased penetration of the liposomes from blood vessels into the extracellular matrix. Surprisingly, penetration depth was independent of the ultrasound intensity used. Ultrasound-mediated delivery of free doxorubicin and the Doxil-like and MMP sensitive liposome resulted in a significant reduction in tumour volume 28 days post the first treatment and increased median survival. The MMP sensitive liposome showed better therapeutic efficacy than the non-MMP sensitive version indicating that cleaving the PEG-layer is important. However, the Doxil-like liposome outcompeted the MMP and non-MMP sensitive liposome, both with and without the use of ultrasound and microbubbles.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleUltrasound-mediated delivery enhances therapeutic efficacy of MMP sensitive liposomesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber121-134en_US
dc.source.volume325en_US
dc.source.journalJournal of Controlled Releaseen_US
dc.identifier.doi10.1016/j.jconrel.2020.06.024
dc.identifier.cristin1820164
dc.relation.projectNorges forskningsråd: 262228en_US
dc.description.localcodeThis is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal